The Estée Lauder Companies Inc. has recently released its 10-K report. The company manufactures, markets and sells skin care, makeup, fragrance and hair care products worldwide, with offerings that range from moisturizers, serums and cleansers to foundations, lipsticks, perfumes, shampoos and conditioners. Its portfolio includes brands such as La Mer, Jo Malone London, TOM FORD, Estée Lauder, Clinique, M·A·C, The Ordinary, Aveda and Bobbi Brown Cosmetics, and it sells through department stores, duty-free shops, specialty retailers, online platforms, freestanding stores and brand websites.
In Item 7, Management’s Discussion and Analysis, the company said its financial condition was shaped by pension funding, market risk management, tax judgments and impairment testing, with the fiscal 2025-to-fiscal 2024 comparison framed around those areas. For its U.S. Qualified Plan, Estée Lauder said it met or exceeded all ERISA contribution requirements in fiscal 2026 and fiscal 2025, and it reported expected benefit payments of $15 million in 2026 and $31 million in 2027 for its non-qualified domestic pension plan, international defined benefit pension plan contributions of $32 million in 2026 and $27 million in 2027, and post-retirement plan benefit payments of $10 million in both 2026 and 2027. The company also said a hypothetical 10% weakening of the U.S. dollar would have reduced the fair value of its foreign currency forward contracts by about $164 million at June 30, 2026, versus $223 million a year earlier, while a similar move would have cut the fair value of cross-currency swaps by about $76 million, versus $85 million, and a 100 basis point rise in interest rates would have lowered the fair value of interest rate derivatives by about $72 million, versus $43 million.
Estée Lauder said it had no off-balance sheet arrangements expected to have a material effect on its financial condition or results of operations. Its critical accounting policies centered on goodwill and other indefinite-lived intangible assets, including trademarks, and income taxes, with management using qualitative and quantitative impairment tests and income-tax estimates based on uncertain tax positions, deferred tax assets and liabilities, and valuation allowances. Today the company's shares have moved 17.95% to a price of $99.40. Check out the company's full 10-K submission here.
